Autoimmune Diseases encompass more than 100+ diseases and are also responsible for multiple life-threatening complications. The prevalence is increasing at par with diseases such as heart disease and cancer.
Autoimmune Diseases are mounting a significant burden on the healthcare infrastructure and the affected person. However, to deal with the rising prevalence, companies such as GSK, R-Pharm, Provention Bio, Tolerion, AbbVie, Gilead Sciences, AstraZeneca, and several others are diligently focussing to offer potential new treatment options.
Discover more about the leading Autoimmune Diseases and the key companies playing a critical role in the development of pipeline products: Autoimmune Diseases Treatment Landscape